HA-1004 HYDROCHLORIDE WEAK PROTEIN KINAS E I(91742-10-8)
- Name: HA-1004 HYDROCHLORIDE WEAK PROTEIN KINAS E I
- Synonyms:
- Molecular Formula:C12H15N5O2S
- Molecular Weight:293.3448
- CAS Registry Number:91742-10-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.91742-10-8 HA-1004 HYDROCHLORIDE WEAK PROTEIN KINAS E I
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.91742-10-8 N-(2-Guanidinoethyl)isoquinoline-5-sulfonamide
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.91742-10-8 HA-1004 HYDROCHLORIDE WEAK PROTEIN KINAS E I
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:HA-1004 HYDROCHLORIDE WEAK PROTEIN KINAS E I
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.91742-10-8 N-(2'-Guanidinoethyl)-5-isoquinolinesulfonamide Dihydrochloride
Assay:97% Appearance:Powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 6956-48-5/(2E)-2-[(4-butyl-1-methyl-2,5-dioxoimidazolidin-4-yl)methylidene]hydrazinecarboxamide
- 3650-31-5/(13E)-15-Hydroxy-8(17),13-labdadiene-19-al
- 38390-48-6/Isolunaridine
- 93165-53-8/Lobelia nicotianaefolia, ext.
- 34987-38-7/Diphezyl
- 34825-93-9/3-(BROMOMETHYL)CYCLOHEXENE
- 132418-48-5/4H-Pyrido(4,3:4,5)thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-9(8H)-carbothioamide, 7,10-dihydro-6-(2-chlorophenyl)-1-methyl-N-(1-methyl-2-phenylethyl)-
- 131466-96-1/Cholestane-3,6,8,15-tetrol,24-[(5-O-sulfo-b-D-xylofuranosyl)oxy]-,monosodium salt, (3b,5a,6a,15b,24S)- (9CI)
- 134934-91-1/9-[2-deoxy-2-(piperidin-1-yl)-beta-D-xylofuranosyl]-9H-purin-6-amine
- 120388-33-2/(3E)-3-[(3-nitrophenyl)methylidene]-5-propylfuran-2(3H)-one
- 128345-62-0/Ranitidinebismuthcitrate
- 88151-91-1/4-[(2E)-2-(2-phenyl-3H-indol-3-ylidene)hydrazinyl]-N-(pyrimidin-2-yl)benzenesulfonamide
- 66843-05-8/5-Methyl-5-(1-methylpentyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
- 19912-62-0/T-muurolol
- 16669-59-3/N-(ISOBUTOXYMETHYL)ACRYLAMIDE
- 91742-10-8/HA-1004 HYDROCHLORIDE WEAK PROTEIN KINAS E I
- 81138-41-2/noradrenaline sulfate
- 110201-30-4/UP 682
- 64755-14-2/Bouvardin
- 69345-02-4/2,6-Methano-1H-azocino[1',2':1,2]pyrido[3,4-b]- indol-7-ium,2,3,4,5,6,14-hexahydro-3- (hydroxymethyl)-1-oxo-,(2R,3R,6R)-
- 34336-43-1/N-methyl(7-methyl-2,3-dihydro-1-benzofuran-2-yl)methanaminium (2Z)-3-carboxyprop-2-enoate
- 108916-86-5/Rutin sulfate
- 332052-65-0/3-ETHOXYCARBONYLAMINO-3-(4-METHOXY-PHENYL)-PROPIONIC ACID
- 7249-75-4/benzyl N-[1-carbamoyl-2-(2-carbamoyl-2-phenylmethoxycarbonylamino-ethy l)disulfanyl-ethyl]carbamate
- 94067-27-3/7-BENZYLOXYGRAMINE
- 135626-21-0/7-hydroxy-6-hydromelodienone
- 53602-03-2/(7aS,8S)-6,7,7a,8-Tetrahydro-8,10-dimethoxy-7-methyl-5H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline
- 97999-42-3/Phenol, reaction products with methanol, p-cresol fraction, motherliquor, reaction products with phosphorus sulfide (P2S5), ammoniu m salts
- 53515-36-9/4-(2-AMINOETHYL)THIOMORPHOLINE
- 3584-23-4/2-(4-Methoxyphenyl)-4,6-bis(trichloromethyl)-1,3,5-triazine